Page last updated: 2024-09-05

sb 203580 and Thrombocytopathy

sb 203580 has been researched along with Thrombocytopathy in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akkerman, JW; Bos, JL; Franke, B; Gorter, G; Hackeng, CM; Relou, IA; van Rijn , HJ1

Other Studies

1 other study(ies) available for sb 203580 and Thrombocytopathy

ArticleYear
Low-density lipoprotein activates the small GTPases Rap1 and Ral in human platelets.
    The Biochemical journal, 2000, Jul-01, Volume: 349, Issue:Pt 1

    Topics: Arachidonic Acid; Blood Platelet Disorders; Blood Platelets; Collagen; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Glutathione Transferase; Humans; Imidazoles; Indomethacin; Ligands; Lipoproteins, LDL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phospholipases A; Phosphorylation; Pyridines; ral GTP-Binding Proteins; rap1 GTP-Binding Proteins; Recombinant Fusion Proteins; Signal Transduction; Thrombin; Thromboxane A2; Time Factors

2000